hers still selling semaglutide Hims cancels plans to sell compounded GLP-1 pill after FDA backlash FDA Blocks Hims & Hers – Hims & Hers to sell

This is the second priority meal

Monitor, do not guess

These studies confirmed the weight lowering efficacy of liraglutide in this setting, showing a BW change ranging from 6.0% to 5.8% with liraglutide compared to 2.0 to 1.5% with placebo 21,22

VSL#3 VSL#3 is the heavyweight of the probiotic world, delivering 450 billion CFU per sachet across eight bacterial strains

Somewhere between the GLP-1 boom, biohacking podcasts, and everyone suddenly tracking their sleep score like its a competitive sport

And if I think like, oh, this is like cardiovascular disease, then then we need to be focusing there, not waiting until things change